Medarex Studying Ipilimumab As First-Line Treatment For Metastatic Melanoma

The registrational trial will compare patients treated with ipilimumab and decarbazine with decarbazine alone.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet